TeraDiscoveries
TeraDiscoveries rapidly discovers novel drugs using cloud computing originally developed at Duke University and first funded by Microsoft.
- Stage $500K in TTM Revenue
- Industry Biotechnology
- Location Durham, NC, USA
- Currency USD
- Founded November 2009
- Employees 12
- Website teradiscoveries.com
Company Summary
TeraDiscoveries (“TD”) disrupts the global pharmaceutical industry. TD accelerates drug discovery by over 100x using "fancy math to sift through hundreds of millions of molecules to find totally novel drugs that cure diseases." The TD platform, which incorporates the breakthrough awarded the 2013 Nobel Prize in Chemistry, is being applied to the entire human proteome preemptively. We have partnered with and received and investment from Microsoft.
Team
-
Shahar KeinanCSO
A computational chemist by background, Dr. Keinan wrote the underlying drug discovery software while a graduate student at Duke.
-
Ed AddisonCEO
www.EdAddison.com
Twice named entrepreneur of the year, Ed is a serial entrepreneur with three past liquidity events.
-
Lawrence HusickCIO
Chemist, patent attorney and computer hacker, Lawrence has started over nine companies and has taken one public.
-
John McGrathDir Biz Dev
John manages our joint marketing program with Microsoft.
-
Elizabeth HobbsComputational Biologist
Ms. Hobbs holds MD degrees in both Molecular Biology and Computer Science.
-
Ken SorensenFinancial Advisor
Dr. Ken Sorensen of Array Capital Management is TeraDiscoveries' financial adviser and board member.
Advisors
-
HutchLaw (pending)LawyerUnconfirmedTechCFO (pending)AccountantUnconfirmed
Previous Investors
-
Angels $1MUnconfirmedMicrosoft $1MUnconfirmedSweat Equity $1MUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.